tweetindex
ES

Stephen V Liu, MD ✓

@StephenVLiu

Thoracic Oncologist, Chief of Heme/Onc @Georgetown @MedStarGUH, Head of Developmental Therapeutics @LombardiCancer, #DCLung26 #TexasLung27 #HereWeGo #LetsGoBucs

30 571Followers
3 632Following
23 402Posts total
18KViews on collected posts

Últimas publicaciones

@StephenVLiu @RManochakian @alexdrilon @IASLC Wonderful discussant @Mal_Itchins 🙌 Bringing it back to the patients who are thriving today because of access to trials and novel agents. Keep on pushing! https://t.co/7G6W2PHtRB
165 views · 5 likes · 0 reposts · 0 replies Open on X →
#WCLC26 Safety profile consistent with ROS1 selectivity. TRAEs in ≥15% of pts included edema, weight gain, blood CPK, dysgeusia, and AST elevation with few G3 TRAEs and discontinuation rate due to TEAE was 4%. https://t.co/41XjEbcMCF
725 views · 5 likes · 0 reposts · 0 replies Open on X →
Dr. @alexdrilon at #WCLC26 presents 1L cohort of ARROS-1 trial of zidesamtinib in pts with ROS1 NSCLC. What a waterfall plot. RR 94% with 15% CR. mPFS not reached, PFS at 6m was 96% and at 12m was 90%. Intracranial RR 100%. In 78 pts who did not have brain metastases at baseline,
10.1K views · 96 likes · 35 reposts · 4 replies Open on X →
@StephenVLiu @DRCamidge @LudaBazhenovaMD @TommyJohn00 @susu_mail0513 @IASLC Well deserved. His work on ALK-driven lung cancer changed outcomes for patients worldwide. Always great to see him recognized like this. 53 views · 0 likes · 0 reposts · 0 replies Open on X →
@StephenVLiu @DRCamidge @LudaBazhenovaMD @TommyJohn00 @susu_mail0513 @IASLC Congrats @DRCamidge!! 68 views · 0 likes · 0 reposts · 0 replies Open on X →
Powerful words praising @DRCamidge at #WCLC26 from @LudaBazhenovaMD @TommyJohn00 @susu_mail0513 echoed by all of us. @IASLC 3.5K views · 57 likes · 11 reposts · 2 replies Open on X →
Standing ovation in support and recognition of Dr Ross Camidge at #WCLC2026 https://t.co/RtTzRAiL7d
3.4K views · 28 likes · 7 reposts · 0 replies Open on X →

Frente a cuentas del mismo tamaño

7 publicaciones de los últimos 90 días, junto al rango de 10K–100K seguidores. por debajo de sus pares en alcance y en interacción.

Visualizaciones medianas725esta cuenta924mediana de 10K–100K
Alcance, %2.37%esta cuenta3.62%mediana de 10K–100K
Interacción, %1.04%esta cuenta1.52%mediana de 10K–100K
MétricaEsta cuentaMediana de 10K–100KProporción
Visualizaciones medianas por publicación7259240.78×
Alcance (visualizaciones ÷ seguidores)2.37%3.62%0.66×
Tasa de interacción1.04%1.52%0.69×

Otras cuentas de este rango →   Comparar con otra cuenta →   Cómo se construyen estas referencias →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

3.4K12 Sep
3.5K
68
53
10.1K14 Sep
725
165

Last 7 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.04%12 Sep
2.01%
0.00%
0.00%
1.38%14 Sep
0.69%
3.03%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.52%.

What the audience does

Likes69.7%191 in total
Reposts19.3%53 in total
Replies2.2%6 in total
Quotes1.8%5 in total
Bookmarks6.9%19 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

Followers by day

13 Sep

Daily snapshots since 13 Sep 2026; the dashed line is the starting count.

Cuentas similares